| Basics |
|
Biofrontera Inc.
|
| IPO Date: |
October 29, 2021 |
| Sector: |
Healthcare |
| Industry: |
Drug Manufacturers - Specialty and Generic |
| Market Cap: |
$9.73M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.13 | 4.99%
|
| Avg Daily Range (30 D): |
$0.03 | 3.54%
|
| Avg Daily Range (90 D): |
$0.03 | 3.13%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.37M |
| Avg Daily Volume (30 D): |
.14M |
| Avg Daily Volume (90 D): |
.12M |
| Trade Size |
| Avg Trade Size (Sh.): |
234 |
| Avg Trade Size (Sh.) (30 D): |
349 |
| Avg Trade Size (Sh.) (90 D): |
267 |
| Institutional Trades |
| Total Inst.Trades: |
27 |
| Avg Inst. Trade: |
$1.17M |
| Avg Inst. Trade (30 D): |
$2.12M |
| Avg Inst. Trade (90 D): |
$2.12M |
| Avg Inst. Trade Volume: |
.01M |
| Avg Inst. Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$.74M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
4.51K |
|
|
| Financials |
| |
TTM |
Q2 2025 |
Q1 2025 |
|
Basic EPS
|
$-.62
|
|
$-.47
|
|
Diluted EPS
|
$-.62
|
|
$-.47
|
|
Revenue
|
$ 6.99M
|
$
|
$ 8.59M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -6.65M
|
$
|
$ -4.2M
|
|
Operating Income / Loss
|
$ -6.28M
|
$
|
$ -4.55M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$
|
$
|
$ -4.12M
|
|
PE Ratio
|
|
|
|
| Splits |
|
Jul 05, 2023:
1:20
|
|
|
|